Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor

Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor

Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor